Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Deciphera Pharmaceuticals, Inc.    DCPH

DECIPHERA PHARMACEUTICALS, INC.

(DCPH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news
Most relevant news about DECIPHERA PHARMACEUTICALS,
10/02DECIPHERA PHARMACEUTICALS : Appoints Matthew L. Sherman, M.D. as Executive Vice ..
BU
10/01DECIPHERA PHARMACEUTICALS : Announces Late-Breaking Oral Presentation at the ESM..
AQ
09/30DECIPHERA PHARMACEUTICALS : Announces Late-Breaking Oral Presentation at the ESM..
BU
09/25DECIPHERA PHARMACEUTICALS, INC. : to Present at the 2019 Cantor Global Healthcar..
BU
09/06DECIPHERA PHARMACEUTICALS : Announces Late-Breaking Oral Presentation of Pivotal..
AQ
09/05DECIPHERA PHARMACEUTICALS : Announces Late-Breaking Oral Presentation of Pivotal..
BU
09/03DECIPHERA PHARMACEUTICALS : Announces Full Exercise of Underwriters' Option to P..
BU
08/19DECIPHERA PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock
BU
08/14DECIPHERA PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
BU
08/14DECIPHERA PHARMACEUTICALS : Announces Positive Top-line Results from INVICTUS Pi..
AQ
08/13DECIPHERA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
BU
08/13DECIPHERA PHARMACEUTICALS : Reports Positive Updated Phase 1 Data for Ripretinib..
BU
08/13DECIPHERA PHARMACEUTICALS : Announces Positive Top-line Results from INVICTUS Pi..
BU
08/05DECIPHERA PHARMACEUTICALS : Announces Second Quarter 2019 Financial Results
AQ
08/02DECIPHERA PHARMACEUTICALS, INC. : Announces Second Quarter 2019 Financial Result..
BU
07/08DECIPHERA PHARMACEUTICALS, INC. : Announces Appointment of Susan L. Kelley, M.D...
BU
06/10DECIPHERA PHARMACEUTICALS, INC. : Expands Pipeline with Potential First-in-Class..
BU
05/30DECIPHERA PHARMACEUTICALS, INC. : to Present at the Jefferies Global Healthcare ..
BU
05/14DECIPHERA PHARMACEUTICALS, INC. : to Present at the UBS Global Healthcare Confer..
BU
05/09DECIPHERA PHARMACEUTICALS, INC. : Announces First Quarter 2019 Financial Results
BU
03/15DECIPHERA PHARMACEUTICALS : Announces Fourth Quarter and Year-end 2018 Financial..
AQ
03/14DECIPHERA PHARMACEUTICALS, INC. : Announces Fourth Quarter and Year-end 2018 Fin..
BU
03/04DECIPHERA PHARMACEUTICALS, INC. : Announces Retirement of Michael D. Taylor, Ph...
BU
02/07DECIPHERA PHARMACEUTICALS, INC. : to Present at the 1st Annual Guggenheim Health..
BU
01/03DECIPHERA PHARMACEUTICALS : Initiates a Phase 1b/2 Clinical Trial of Rebastinib ..
BU
01/02DECIPHERA PHARMACEUTICALS : Announces Positive, Preliminary, Top-Line Clinical D..
BU
01/02DECIPHERA PHARMACEUTICALS, INC. : to Present at the 37th Annual J.P. Morgan Heal..
BU
2018DECIPHERA PHARMACEUTICALS : Initiates Pivotal Phase 3 Clinical Study of Ripretin..
AQ
2018DECIPHERA PHARMACEUTICALS : Initiates Pivotal Phase 3 Clinical Study of Ripretin..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Present at the 30th Annual Piper Jaffray He..
BU
2018DECIPHERA PHARMACEUTICALS : Completes Enrollment in the INVICTUS Pivotal Phase 3..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : Announces Third Quarter 2018 Financial Results
BU
2018DECIPHERA PHARMACEUTICALS : Initiates a Phase 1b/2 Clinical Trial of Rebastinib ..
AQ
2018DECIPHERA PHARMACEUTICALS : Initiates a Phase 1b/2 Clinical Trial of Rebastinib ..
BU
2018DECIPHERA PHARMACEUTICALS : Reports Updated Preliminary Phase 1 Clinical Study R..
AQ
2018DECIPHERA PHARMACEUTICALS : Reports Updated Preliminary Phase 1 Clinical Study R..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Present at the 2018 Cantor Global Healthcar..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Participate in Citi's 13th Annual Biotech C..
BU
2018U.S. hedge funds bet on retail, tech in second-quarter as economy sizzled
RE
2018DECIPHERA PHARMACEUTICALS, INC. : Announces Second Quarter 2018 Financial Result..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Present at the 38th Annual Canaccord Genuit..
BU
2018DECIPHERA PHARMACEUTICALS : Announces Full Exercise of Underwriters' Option to P..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Present at the JMP Securities 2018 Life Sci..
BU
2018DECIPHERA PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock
BU
2018DECIPHERA PHARMACEUTICALS : Announces Pricing of Public Offering
BU
2018DECIPHERA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
BU
2018DECIPHERA PHARMACEUTICALS : Reports Updated Interim Phase 1 Clinical Study Resul..
BU
2018CORRECTION FROM SOURCE : Xiana Enters into a Long Term Mining Assignment of an A..
NE
2018Xiana Enters into a Long Term Mining Assignment of an Advanced Exploration Pr..
NE
2018DECIPHERA PHARMACEUTICALS : Appoints Stephen B. Ruddy, Ph.D. as Chief Technical ..
BU
2018Xiana to Acquire Producing Copper Operation in Chile and Announces Financing ..
NE
2018DECIPHERA PHARMACEUTICALS : Expands Board with the Election of Mr. Steven L. Hoe..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Present at Upcoming Investor Conferences
BU
2018DECIPHERA PHARMACEUTICALS, INC. : Announces First Quarter 2018 Financial Results
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Report Clinical Data with DCC-2618 at the U..
BU
2018DECIPHERA PHARMACEUTICALS : Preclinical Data Demonstrate That Deciphera Pharmace..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : Reports Updated Data from Ongoing Phase 1 Clin..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : Announces Fourth Quarter 2017 Financial Result..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Report Clinical and Preclinical Data with D..
BU
2018DECIPHERA PHARMACEUTICALS, INC. : to Present at the 36th Annual J.P. Morgan Heal..
BU
2017Deciphera Pharmaceuticals, Inc. Added to Russell 2000® Index
GL
2017Deciphera Pharmaceuticals, Inc. Announces Orphan Drug Designation from the EM..
GL
2017Deciphera Pharmaceuticals, Inc. to Present at the 29th Annual Piper Jaffray H..
GL
2017Deciphera Pharmaceuticals Reports Data from Ongoing Phase 1 Clinical Study of..
GL
2017Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial Result..
GL
2017Deciphera Pharmaceuticals, Inc. Reports Data Analysis from the Ongoing Phase ..
GL
2017Deciphera Pharmaceuticals, Inc. to Report Clinical Data with DCC-2618 at the ..
GL
2017Deciphera Pharmaceuticals Announces Closing of Initial Public Offering and Ex..
GL
Upcoming event on DECIPHERA PHARMACEUTICALS,